Cointime

Download App
iOS & Android

Nektar Therapeutics

company
Funding Round
Post-IPO Equity
Money Raised
$ 25M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
AstraZeneca - Yes - Detail